Recent Posts
![[Clinical Rounds] A Multidisciplinary Management Approach to Cervical Cancer During Pregnancy](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/5281f8873aca1a3c24d65c4c50a98a5f.webp)
News•Feb 18, 2026
[Clinical Rounds] A Multidisciplinary Management Approach to Cervical Cancer During Pregnancy
A 39‑year‑old gravida 3 woman presented at 10 weeks gestation with vaginal bleeding and a prior diagnosis of high‑grade squamous intraepithelial lesion (HSIL) that had not been followed up. Cervical cancer testing confirmed HSIL while the intrauterine pregnancy remained viable. The case highlights the need for a coordinated, multidisciplinary management plan involving obstetrics, oncology, surgery, and pathology. Treatment options must balance maternal cancer control with fetal preservation, often requiring staged interventions and careful timing of delivery.
By The Lancet
![[Comment] New Dietary Guidelines for Americans: A Recipe for Poorer Health](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/825e543f26c81223af4db3a2ab8c08ce.webp)
News•Feb 16, 2026
[Comment] New Dietary Guidelines for Americans: A Recipe for Poorer Health
On Jan 7, 2026, HHS and USDA issued the 10th edition of the Dietary Guidelines for Americans. The new guidelines replace a decades‑long transparent, evidence‑based process with a conflicted, less rigorous framework. Critics argue the recommendations are contradictory and often lack scientific...
By The Lancet
![[Correspondence] Dietary Evidence and the 2025–2030 US Guidelines](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/afeb2aae29a5f0f61f35b88b57552977.webp)
News•Feb 16, 2026
[Correspondence] Dietary Evidence and the 2025–2030 US Guidelines
The U.S. Departments of Health and Human Services and Agriculture have released the 2025‑2030 Dietary Guidelines, introducing a revised pyramid that elevates animal‑based proteins, full‑fat dairy, and saturated fats. The correspondence questions whether this shift aligns with the broader global...
By The Lancet
![[Articles] Lisocabtagene Maraleucel in Patients with Relapsed or Refractory Marginal Zone Lymphoma (TRANSCEND FL): Primary Analysis Results From the Global,...](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/25fa63f0facda490c948dbe35f77e586.webp)
News•Feb 12, 2026
[Articles] Lisocabtagene Maraleucel in Patients with Relapsed or Refractory Marginal Zone Lymphoma (TRANSCEND FL): Primary Analysis Results From the Global,...
Lisocabtagene maraleucel, a CD19-directed CAR‑T therapy, demonstrated high overall response rates and durable remissions in patients with relapsed or refractory marginal zone lymphoma (MZL) in the phase 2 TRANSCEND FL trial. The global, multicohort, single‑arm study reported an 82 % overall response...
By The Lancet